InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Flynn Patrick John, Director. Officer active across 1 company, notably NRX Pharmaceuticals, Inc.. In total, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €3k. History available since 28 November 2022. The latest transaction was filed on 28 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
2,500 shares@ US$1.25100.0% of flowCommon Stock, par value $0.001 per shareSEC:0001415889-22-011810:0
Ideal exit: 25 Aug 2023 (T+270)
362,332 sharesCommon StockSEC:0000950142-21-001938
362,332 sharesCommon StockSEC:0000950142-21-001938:0
3 of 3 declarations
About Flynn Patrick John
Patrick John Flynn is a Director at NRX Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to provide informed perspectives on the challenges and opportunities faced by the company. He plays a key role in guiding strategies aimed at ensuring the growth and sustainability of NRX Pharmaceuticals.
